Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06234995
PHASE4

Cortical Electrophysiology of Response Inhibition in Parkinson's Disease

Sponsor: Emory University

View on ClinicalTrials.gov

Summary

Patients with Parkinson's Disease will be studied before, during, and after a deep brain stimulation implantation procedure to see if the stimulation location and the size of the electrical field produced by subthalamic nucleus (STN) DBS determine the degree to which DBS engages circuits that involve prefrontal cortex executive functions, and therefore have a direct impact on the patient's ability to inhibit actions.

Key Details

Gender

All

Age Range

45 Years - 75 Years

Study Type

INTERVENTIONAL

Enrollment

80

Start Date

2021-08-09

Completion Date

2026-07

Last Updated

2026-03-27

Healthy Volunteers

Yes

Interventions

DRUG

Levodopa

Participants will take levodopa in dosages prescribed by their care provider. Patients will be instructed to not take their regularly prescribed PD medications for 12 hours prior to the study assessment, as is typical for clinical evaluations in patients with PD. Participants will be tested in both levodopa-off (after 12 hours of not having medication) and levodopa-on states.

DEVICE

Clinical DBS Setting

Deep brain stimulation performed with the patients' optimized clinical setting.

DEVICE

Sham DBS

Deep brain stimulation performed with sham stimulation.

DEVICE

DBS Setting Maximizing Prefrontal Activation

Deep brain stimulation performed to maximize the activation of the prefrontal cortico-STN projections.

DEVICE

DBS Setting Minimizing Prefrontal Activation

Deep brain stimulation performed to minimize the activation of the prefrontal cortico-STN projections.

Locations (2)

Emory University Hospital

Atlanta, Georgia, United States

Emory Brain Health Center

Atlanta, Georgia, United States